Skip to main content

Advertisement

Log in

Essentials from clinical practice guidelines for CKD stage G3b-5 2017

Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ACE:

Angiotensin converting enzyme

AKI:

Acute kidney injury

ARB:

Angiotensin receptor blocker

BMI:

Body mass index

CCB:

Calcium channel blocker

CKD:

Chronic kidney disease

CVD:

Cardiovascular disease

eGFR:

Estimated glomerular filtration rate

ESKD:

End-stage kidney disease

GNRI:

Geriatric nutritional risk index

QOL:

Quality of life

RAS:

Renin angiotensin system

Acknowledgements

Production of these guidelines was supported by a Grant-in-Aid for Research on Advanced Chronic Kidney Disease, Practical Research Project for Renal Diseases from the Japan Agency for Medical Research and Development, AMED.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Hirokazu Okada.

Ethics declarations

Conflict of interest

All committee members involved in producing this guideline submitted conflict-of-interest statements based on the AMED rules.

Additional information

Research team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED published Clinical Practice Guidelines for CKD stage G3b-5 2017 (in Japanese) in Journal of Japanese Society of Nephrology (in press). This is the English, digest version of that guideline.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okada, H., Research Team for a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J). & Practical Research Project for Renal Diseases from Japan Agency for Medical Research and Development, AMED. Essentials from clinical practice guidelines for CKD stage G3b-5 2017. Clin Exp Nephrol 22, 245–248 (2018). https://doi.org/10.1007/s10157-018-1532-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-018-1532-z

Navigation